Case Control Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Apr 21, 2023; 29(15): 2310-2321
Published online Apr 21, 2023. doi: 10.3748/wjg.v29.i15.2310
Table 2 Comparison of visceral fat characteristics between the two lesions
Variable
PM (+) (n = 43)
PM (-) (n = 85)
P value
ICC
VFROI 1
Volume (cc)84.45 (36.70, 161.04)87.92 (49.89, 160.75)0.4120.913
Mean attenuation (HU)-82.07 ± 6.06-85.33 ± 5.890.04410.810
SD attenuation (HU)18.82 (17.78, 21.25)19.51 (18.63, 21.11)0.1330.926
SFROI 1
Volume (cc)108.79 (55.10, 170.90)115.96 (62.70, 178.72)0.7600.979
Mean attenuation (HU)-85.33 ± 5.89-86.05 ± 8.230.9340.955
SD attenuation (HU)17.94 (16.60, 19.37)18.58 (17.27, 20.16)0.1800.981
VFROI 2
Volume (cc)132.63 (58.85, 273.65)145.48 (82.58, 277.42)0.3020.932
Mean attenuation (HU)-82.19 ± 5.35-85.70 ± 5.650.00110.974
SD attenuation (HU)19.86 (17.58, 20.46)19.13 (18.47, 20.66)0.3170.950
SFROI 2
Volume (cc)163.24 (82.57, 261.17)175.86 (97.86, 267.52)0.760.991
Mean attenuation (HU)-86.28 ± 8.61-86.41 ± 8.080.9380.980
SD attenuation (HU)17.80 (16.42, 19.33)18.45 (17.29, 19.91)0.1240.993
Volume ratio
VF/SFROI 10.92 (0.44, 1.50)1.00 (0.61, 1.65)0.3170.804
VF/SFROI 20.98 (0.47, 1.41)1.00 (0.63, 1.68)0.2790.884